<SEC-DOCUMENT>0001493152-24-035783.txt : 20240911
<SEC-HEADER>0001493152-24-035783.hdr.sgml : 20240911
<ACCEPTANCE-DATETIME>20240911160512
ACCESSION NUMBER:		0001493152-24-035783
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20240910
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240911
DATE AS OF CHANGE:		20240911

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sanara MedTech Inc.
		CENTRAL INDEX KEY:			0000714256
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				592220004
		STATE OF INCORPORATION:			TX
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39678
		FILM NUMBER:		241292640

	BUSINESS ADDRESS:	
		STREET 1:		1200 SUMMIT AVE
		STREET 2:		SUITE 414
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76102
		BUSINESS PHONE:		817-529-2300

	MAIL ADDRESS:	
		STREET 1:		1200 SUMMIT AVE
		STREET 2:		SUITE 414
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WOUND MANAGEMENT TECHNOLOGIES, INC.
		DATE OF NAME CHANGE:	20080611

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MB SOFTWARE CORP
		DATE OF NAME CHANGE:	19960805

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INAV TRAVEL CORPORATION
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:SMTI="http://sanaramedtech.com/20240910">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_033_SMTI_sanaramedtech.com_20240910 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20240910_20240910 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DEntityCentralIndexKey_0000714256 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-09-10" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-09-10" id="Fact000004" name="dei:EntityCentralIndexKey">0000714256</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="smti-20240910.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-09-10">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000714256</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-10</xbrli:startDate>
        <xbrli:endDate>2024-09-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt">UNITED
STATES</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt">SECURITIES
AND EXCHANGE COMMISSION</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt">FORM
<span id="xdx_902_edei--DocumentType_c20240910__20240910_z5vtqjnec9ni"><ix:nonNumeric contextRef="AsOf2024-09-10" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) of the</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): <b><span id="xdx_901_edei--DocumentPeriodEndDate_c20240910__20240910_zskbucDMv0Qa"><ix:nonNumeric contextRef="AsOf2024-09-10" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">September 10, 2024</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_909_edei--EntityRegistrantName_c20240910__20240910_zcjS7q4AUYKa"><ix:nonNumeric contextRef="AsOf2024-09-10" id="Fact000011" name="dei:EntityRegistrantName">SANARA
MEDTECH INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityIncorporationStateCountryCode_c20240910__20240910_zehTMcqnLbGg"><ix:nonNumeric contextRef="AsOf2024-09-10" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Texas</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--EntityFileNumber_c20240910__20240910_zspPbdQZFhgg"><ix:nonNumeric contextRef="AsOf2024-09-10" id="Fact000013" name="dei:EntityFileNumber">001-39678</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90F_edei--EntityTaxIdentificationNumber_c20240910__20240910_z5c2VrButbzi"><ix:nonNumeric contextRef="AsOf2024-09-10" id="Fact000014" name="dei:EntityTaxIdentificationNumber">59-2219994</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    or other jurisdiction </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(IRS
    Employer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">File <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityAddressAddressLine1_c20240910__20240910_zhsxHzyq3Rtd"><ix:nonNumeric contextRef="AsOf2024-09-10" id="Fact000015" name="dei:EntityAddressAddressLine1">1200
    Summit Avenue</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressAddressLine2_c20240910__20240910_z38feHpKf2pk"><ix:nonNumeric contextRef="AsOf2024-09-10" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 414</ix:nonNumeric></span></b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_904_edei--EntityAddressCityOrTown_c20240910__20240910_zmUL4wLATwi1"><ix:nonNumeric contextRef="AsOf2024-09-10" id="Fact000017" name="dei:EntityAddressCityOrTown">Fort
    Worth</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressStateOrProvince_c20240910__20240910_zF5HdyIKVtQb"><ix:nonNumeric contextRef="AsOf2024-09-10" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">Texas</ix:nonNumeric></span></b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_903_edei--EntityAddressPostalZipCode_c20240910__20240910_zRpnpaOQqf7j"><ix:nonNumeric contextRef="AsOf2024-09-10" id="Fact000019" name="dei:EntityAddressPostalZipCode">76102</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&#8217;s
telephone number, including area code: <b><span id="xdx_908_edei--CityAreaCode_c20240910__20240910_zTXKObXauyn4"><ix:nonNumeric contextRef="AsOf2024-09-10" id="Fact000020" name="dei:CityAreaCode">(817)</ix:nonNumeric></span> <span id="xdx_90D_edei--LocalPhoneNumber_c20240910__20240910_zwOztuD3kQli"><ix:nonNumeric contextRef="AsOf2024-09-10" id="Fact000021" name="dei:LocalPhoneNumber">529-2300</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Not
Applicable</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--WrittenCommunications_c20240910__20240910_z4TRNiNTRNHj"><ix:nonNumeric contextRef="AsOf2024-09-10" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_edei--SolicitingMaterial_c20240910__20240910_zDDhmOaPu11g"><ix:nonNumeric contextRef="AsOf2024-09-10" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--PreCommencementTenderOffer_c20240910__20240910_zUGfAjehOb5c"><ix:nonNumeric contextRef="AsOf2024-09-10" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--PreCommencementIssuerTenderOffer_c20240910__20240910_zsdOvP00tln2"><ix:nonNumeric contextRef="AsOf2024-09-10" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 38%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt; width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 20%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; padding-bottom: 1pt; width: 2%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 38%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_edei--Security12bTitle_c20240910__20240910_zmkUIMlYf8H5"><ix:nonNumeric contextRef="AsOf2024-09-10" id="Fact000026" name="dei:Security12bTitle">Common
    Stock, $0.001 par value</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--TradingSymbol_c20240910__20240910_zNSsHXvZekxb"><ix:nonNumeric contextRef="AsOf2024-09-10" id="Fact000027" name="dei:TradingSymbol">SMTI</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>The
    <span id="xdx_90A_edei--SecurityExchangeName_c20240910__20240910_zkbJudIjHIA5"><ix:nonNumeric contextRef="AsOf2024-09-10" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 0pt; text-align: right; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_906_edei--EntityEmergingGrowthCompany_c20240910__20240910_zjbnyTUMYwL2"><ix:nonNumeric contextRef="AsOf2024-09-10" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
7.01 Regulation FD Disclosure.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 11, 2024, Sanara MedTech Inc. (the &#8220;Company&#8221;) issued a press release announcing the Unit Purchase Agreement
(defined below). A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference
herein.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information included under Item 7.01 (including Exhibit 99.1) is furnished pursuant to Item 7.01 and shall not be deemed &#8220;filed&#8221;
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;), or otherwise be subject to
the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933,
as amended, or the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in
such filing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
8.01 Other Events. </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 10, 2024, Sanara CMP LLC, a wholly owned subsidiary of the Company (&#8220;Sanara CMP&#8221;), entered into a Unit Purchase
Agreement (the &#8220;Unit Purchase Agreement&#8221;) with ChemoMouthpiece, LLC (&#8220;CMp&#8221;), pursuant to which Sanara CMP purchased
100,674.72 common units in CMp for $5.0 million, which represents approximately 6.64% of the issued and outstanding membership interests
of CMp immediately following such purchase. CMp is a privately held medical device company that develops and commercializes propriety
oral cryotherapy products for cancer patients, including, among other things, CMp&#8217;s Chemo Mouthpiece<sup>&#174;</sup> oral cryotherapy
device, which is a 510(k) cleared cryotherapy device designed to reduce the incidence and severity of chemotherapy induced oral mucositis.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Unit Purchase Agreement, the Company, CMp, certain subsidiaries of CMp, InfuSystem, Inc. (&#8220;InfuSystem&#8221;)
and SI Healthcare Technologies, LLC, a joint venture entity owned 50/50 by the Company and InfuSystem (&#8220;SI Technologies&#8221;),
entered into an Exclusive Distribution Agreement (the &#8220;Distribution Agreement&#8221;) pursuant to which SI Technologies was appointed
as the sole and exclusive U.S. distributor of CMp&#8217;s Standard Chemo Regiment Kits, each kit consisting of the Chemo Mouthpiece<sup>&#174;
</sup>oral cryotherapy device and associated materials used in the treatment of oral mucositis (the &#8220;Product&#8221;), for a
term of five years. In addition, the parties to the Distribution Agreement entered into an Intellectual Property Rights Agreement pursuant
to which SI Technologies was granted the exclusive right to use CMp&#8217;s intellectual property rights to permit resale and use of
the Product in the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 4, 2024, the Company, pursuant to its option under its previously disclosed Term Loan Agreement with CRG Servicing LLC dated
as of April 17, 2024 (the &#8220;Loan Agreement&#8221;) borrowed an additional $15.5 million under the Loan Agreement (the &#8220;Second
Borrowing&#8221;). As previously disclosed, the Loan Agreement provides for up to a $55.0 million term loan facility, $15.0 million of
which was borrowed at closing on April 17, 2024 (the &#8220;First Borrowing&#8221;). The First Borrowing and the Second Borrowing each
have a maturity date of May 30, 2029, unless earlier prepaid, and bear interest at 13.25% per annum rate. Pursuant to the Loan Agreement,
prior to June 30, 2025 and subject to the satisfaction of certain conditions, the Company has the right to draw down a third borrowing
of up to $24.5 million. The Company used $5.0 million of the proceeds of the Second Borrowing for the investment in CMp and intends to
use the remaining proceeds for permitted acquisition opportunities and for general working capital and corporate purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
description of the Loan Agreement included in Item 1.01 of the Company&#8217;s Current Report on Form 8-K filed on April 18, 2024 (the
&#8220;April 2024 8-K&#8221;), is incorporated herein by reference. The description of the Loan Agreement contained herein does not purport
to be complete, and is qualified in its entirety by reference to the complete text of the Loan Agreement filed as Exhibit 10.1 to the
April 2024 8-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01 Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Exhibits </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="padding-bottom: 1pt; width: 0.1in">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="ex99-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press Release issued September 11, 2024 (furnished pursuant to Item 7.01).</span></a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td>&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    September 11, 2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sanara
    MedTech Inc</b>.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Michael D. McNeil</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">Name:</td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Michael D. McNeil</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">Chief Financial Officer </td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjU0KwkAMhU/QO4RZi05bXdidFi1iFSkibkebymA7KZnx70je0rFFDA9CeO/LE2IgMlrqGhmO8yKHPTZtrRxCgRUymjP6RLpaJ+B3gRdtHSvjuvMHpuQZ9MxkGMUnb3TRu7ZYJiCnI69oDKFMZAyzjQi+fkqm0iUap1UNypSwY2pZo1P86j/s1ZMMNa+u6oBsNZkEwqHs7TdEMoxgS3f1IL5ayPNUBINuApEx3VqfWjwdmi8JixobX2d7+q/gAwCASoE= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="height: 57.75pt; width: 172.5pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Sanara
MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in,
ChemoMouthpiece, LLC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>FORT
WORTH, TX / GlobeNewswire / September 11, 2024 /&nbsp;Sanara MedTech Inc</B>. Based in Fort Worth, Texas, Sanara MedTech Inc. (&ldquo;Sanara,&rdquo;
the &ldquo;Company,&rdquo; &ldquo;we,&rdquo; &ldquo;our&rdquo; or &ldquo;us&rdquo;) (NASDAQ: SMTI), a medical technology company focused
on improving clinical outcomes and reducing healthcare expenditures in the surgical, chronic wound and skincare markets, and InfuSystem,
Inc. (&ldquo;InfuSystem&rdquo;), the operational subsidiary of Sanara&rsquo;s joint venture partner InfuSystem Holdings, Inc., announced
today the execution of an exclusive United States distribution agreement with, and minority investment in, ChemoMouthpiece, LLC (&ldquo;ChemoMouthpiece&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Ron
Nixon, Sanara&rsquo;s CEO, stated, &ldquo;Oral mucositis is a debilitating condition impacting hundreds of thousands of oncology patients
annually. ChemoMouthpiece has developed a clinically validated product with FDA 510(k) clearance that can bring relief to affected patients.
The American Medical Association has recently issued the CPT code (effective July 2024) to be applied for potential reimbursement by
physicians and payers for the use of an oral cavity device for a cryotherapy procedure in conjunction with chemotherapy. The product
aligns well with Sanara&rsquo;s skincare strategy, which includes the licensed collagen peptides from Tufts University that focus on
radiation dermatitis. We look forward to providing the Chemo Mouthpiece&reg; oral cryotherapy device to oncology patients undergoing
chemotherapy.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Transaction
Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ChemoMouthpiece
                                            owns and manufactures a 510(k) cleared device that uses cryotherapy to reduce the incidence
                                            and severity of oral mucositis in patients undergoing stomatotoxic chemotherapy treatments.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SI
                                            Healthcare Technologies, LLC (f/k/a SI Wound Care, LLC) (&ldquo;SI Technologies&rdquo;),
                                            a 50/50 joint venture between Sanara and InfuSystem, will be the exclusive&nbsp;distributor
                                            of ChemoMouthpiece&rsquo;s kits in the United States.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SI
                                            Technologies plans to&nbsp;market and distribute the product through InfuSystem to approximately
                                            3,000 cancer centers&nbsp;through InfuSystem&rsquo;s existing sales team.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SI
                                            Technologies will purchase&nbsp;the product kits from ChemoMouthpiece at a fixed price and
                                            pay a royalty on net revenues for the use of the product intellectual property. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sanara
                                            invested $5 million for a 6.6% ownership position in ChemoMouthpiece.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SI
                                            Technologies will have a purchase option that expires on January 31, 2029 to purchase the
                                            U.S. business of ChemoMouthpiece, including all U.S. intellectual property related to the
                                            product.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sanara
                                            has drawn $15.5 million on its term loan with CRG Servicing, LLC and will fund this investment
                                            as part of that draw.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Oral
Mucositis</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Oral
mucositis causes painful mouth ulcers, which are a common complication of chemotherapy and radiation. In the U.S., there are an estimated
500,000 &ndash; 1,000,000 patients who have oral mucositis annually and the estimated market size exceeds $600 million. SI Technologies
believes this product will show material cost reductions for oncology treatment centers, improve patient quality of life and allow for
continued treatment of cancer therapy for patients. ChemoMouthpiece is planning to publish studies in the future reinforcing the efficacy
of their product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Richard
Dilorio, InfuSystem&rsquo;s CEO, stated, &ldquo;Sanara and InfuSystem entered into our partnership in order to bring together our combined
technical, operational and commercial strengths to deliver proprietary efficacious products to patients. We believe this exclusive agreement,
which builds on our partnership, will allow us to do that by offering the <FONT STYLE="background-color: white">Chemo Mouthpiece&reg;
oral cryotherapy device</FONT> and bringing potential relief to thousands of cancer patients suffering from oral mucositis.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
Yoskowitz, ChemoMouthpiece&rsquo;s President and CEO stated, &ldquo;We are pleased to have selected SI Technologies as our exclusive
distribution partner in the United States. We believe that InfuSystem&rsquo;s experienced team of seasoned oncology professionals currently
calling on approximately 3,000 U.S. cancer centers will accelerate the uptake of the Chemo Mouthpiece, bringing a much-needed option
for patients that would otherwise suffer from the debilitating effects of oral mucositis.&rdquo; David added, &ldquo;We understand that
the executive team of SI Technologies has a long history of launching products into the oncology space, and coupled with Sanara&rsquo;s
ownership position in ChemoMouthpiece, we are confident that they will execute the successful launch of the <FONT STYLE="background-color: white">Chemo
Mouthpiece&reg; oral cryotherapy device</FONT>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pickwick
Capital Partners, LLC, served as the exclusive advisor to ChemoMouthpiece on this transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>About
ChemoMouthpiece, LLC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">ChemoMouthpiece,
LLC is a privately held medical device company that develops and commercializes propriety oral cryotherapy products for cancer patients.
The Chemo Mouthpiece&reg; oral cryotherapy device was developed based on the personal experience of inventor, founder and CEO, David
Yoskowitz, who when diagnosed with Hodgkin&rsquo;s Lymphoma, experienced oral mucositis firsthand. His treatment options included ice
chips to mitigate and minimize the pain. Yet this caused nausea, was difficult to maintain in his mouth, and did not effectively cool
the entire oral cavity which led him to search for a better option. The Chemo Mouthpiece&reg; oral cryotherapy device cools down the
entire oral cavity, causing vasoconstriction, which in effect slows and reduces the flow of chemotherapy in the oral cavity, thus greatly
reducing the risk of developing oral mucositis. The cryotherapy approach has been positively studied for decades and the Chemo Mouthpiece&reg;
oral cryotherapy device has significant and improved advantages over conventional cryotherapy interventions. For more information on
ChemoMouthpiece, LLC, please visit its website at www.chemomouthpiece.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>About
Sanara MedTech Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Sanara
MedTech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical
outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. The Company markets, distributes and
develops surgical, wound and skincare products for use by physicians and clinicians in hospitals, clinics and all post-acute care settings
and offers wound care and dermatology virtual consultation services via telemedicine. Sanara&rsquo;s products are primarily sold in the
North American advanced wound care and surgical tissue repair markets. Sanara markets and distributes CellerateRX<SUP>&reg;</SUP> Surgical
Activated Collagen, FORTIFY TRG<SUP>&reg;</SUP> Tissue Repair Graft and FORTIFY FLOWABLE<SUP>&reg;</SUP> Extracellular Matrix as well
as a portfolio of advanced biologic products focusing on ACTIGEN<SUP>TM</SUP> Verified Inductive Bone Matrix, ALLOCYTE<SUP>&reg;</SUP>
Plus Advanced Viable Bone Matrix, BiFORM<SUP>&reg;</SUP> Bioactive Moldable Matrix, TEXAGEN<SUP>&reg;</SUP> Amniotic Membrane Allograft,
and BIASURGE<SUP>&reg;</SUP> Advanced Surgical Solution to the surgical market. In addition, the following products are sold in the wound
care market: BIAKOS<SUP>&reg;</SUP> Antimicrobial Skin and Wound Cleanser, BIAKOS<SUP>&reg;</SUP> Antimicrobial Wound Gel,
and BIAKOS<SUP>&reg;</SUP> Antimicrobial Skin and Wound Irrigation Solution. Sanara&rsquo;s pipeline also contains potentially
transformative product candidates for mitigation of opportunistic pathogens and biofilm, wound re-epithelialization and closure, necrotic
tissue debridement and cell compatible substrates. The Company believes it has the ability to drive its pipeline from concept to preclinical
and clinical development while meeting quality and regulatory requirements. Sanara is constantly seeking long-term strategic partnerships
with a focus on products that improve outcomes at a lower overall cost.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"></FONT></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>About
InfuSystem Holdings, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">InfuSystem
Holdings, Inc. (NYSE American: INFU), is a leading national health care service provider, facilitating outpatient care for durable medical
equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient
Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical
equipment and services. The Patient Services segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second
platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business
from its direct payer clients. The Device Solutions segment is comprised of direct payer rentals, pump and consumable sales, and biomedical
services and repair. Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support and also operates
Centers of Excellence in Michigan, Kansas, California, Massachusetts, Texas and Ontario, Canada<FONT STYLE="background-color: white">.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><FONT STYLE="background-color: white">&nbsp;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Information
about Forward-Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
statements in this press release that do not constitute historical facts are &ldquo;forward-looking statements,&rdquo; within the meaning
of and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. These statements may be identified
by terms such as &ldquo;aims,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo; contemplates,&rdquo; &ldquo;continue,&rdquo;
&ldquo;could,&rdquo; &ldquo;estimates,&rdquo; &ldquo;expect,&rdquo; &ldquo;forecast,&rdquo; &ldquo;guidance,&rdquo; &ldquo;intend,&rdquo;
&ldquo;may,&rdquo; &ldquo;plan,&rdquo; &ldquo;possible,&rdquo; &ldquo;potential,&rdquo; &ldquo;predicts,&rdquo; &ldquo;preliminary,&rdquo;
&ldquo;projects,&rdquo; &ldquo;seeks,&rdquo; &ldquo;should,&rdquo; &ldquo;targets,&rdquo; &ldquo;will&rdquo; or &ldquo;would,&rdquo;
or the negatives of these terms, variations of these terms or other similar expressions. These forward-looking statements include, among
others, statements regarding the ability to market and distribute the Chemo Mouthpiece device. These items involve risks, contingencies
and uncertainties such as the ability to penetrate oncology hospitals and clinics, the extent of product demand, market and customer
acceptance, the effect of economic conditions, competition, pricing, uncertainties associated with the development and process for obtaining
regulatory approval for new products, the ability to consummate and integrate acquisitions, and other risks, contingencies and uncertainties
detailed in the Company&rsquo;s SEC filings, which could cause the Company&rsquo;s actual operating results, performance or business
plans or prospects to differ materially from those expressed in, or implied by these statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">All
forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to revise any of
these statements to reflect the future circumstances or the occurrence of unanticipated events, except as required by applicable securities
laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>Investor
Contact:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Callon
Nichols, Director of Investor Relations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">713-826-0524</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><U>CNichols@sanaramedtech.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B>SOURCE:
Sanara MedTech Inc</B>. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" "P @X# 2(  A$! Q$!_\0
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M&.0_1<9;US]IWXW_  +_ &6_A3JO[3?Q\N+:RT?P?:-*VJ'3Q/<Q&1EC$,
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MHR/6@ HHS10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MGACX&SSQ^*KWP[-%HQM;CR9GD.-R1OD;'9-RJV1AF'(K\I/^"37A+XT?L_\
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M.H0VEG:0--=75S*$CAC499V8\*H ))/ %>1F^3XS)<=]5Q%G*R?NNZUV^?\
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M$X"@!\DD\ #K724G&4=T"E&6S"BLOQ'XY\$^#WBC\6^,-+TMIP3 NI:A' 9
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MYV5/SZ_9$_X+H?"+]C#]HG4O$_P"_P""=O@'PEX#UW4/)U:/2[J]G\0?V>9
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MY+A<CX;IT<FRVDX4W&4XV4I0M>[O-MZMRNKO;;H>T4445XY]*%%%% !7X/\
M_!W)8^)$_:-^$>I73M_8\O@J]BL5W<"Y6[S.<=OD>W^N/:OW@KXH_P""X_\
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MQ7Y;_P#!;7_@O8/V/=9O_P!E/]D2>ROOB.L!3Q%XFF5+BV\-%E^6.-,E9;P
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MOPOUQM+U"UB\JV\40Q:;*9'"CY8;H ,[QKA' 9D"@%%_5KQOX$\%?$KPE?>
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MV@WL5K'.H31RA6:"UB16GD!=]SW!15!6)0%(R_SY^SK_ ,&SOPY_:0\1Z?\
M%[X1_M]^'?&'P:NM4++J&@::YU66V23+VC9/E07 3Y2S#*L=QBQ\M<Y_P<__
M +,O[3"_MRV_Q\N_#VMZ]X%USPO8VGA[4+&QEGM]': %9K%RJD1,TI>X . X
MN#C)5@.[_P""17Q3^.'_  2._P""7OQG_;3^./@/5%T?Q)KVD6_PQ\&:T9K0
MW^H#SX9KG8RYCBD$D1,F 76R;&?D)^XB\='+EC:&(O5JN*:]VS;TLE;1Q6[\
MG<^*E'!2S!X*OA[4J2DT_>NDM6V[ZJ3V7FC?;_@KI^VSX#_:(C\+>$M3M['P
MQH.M+HNF_#M=#@:*.RAE$*6A<IYQEVH%,F\-NSC:#MK]#O\ @J3_ ,$R? ?_
M  5$^!>E_"OQ3\0[[PEJFA:P-3T/7K2Q%VL$AC:.2.6W+QB5&1NSHRLJD'&Y
M6_*G_@GA_P %M-/^-W_!1#PO>_M<_LE_"N2[\;>(K?3;'QCX:\-R6]]I6H7$
M@BMIV\V:1)5\QD1I& E53O#G;M;]]ACJ*PXKQ='#XK#/"894)PCJU9\ST[+6
MUGK+5WU.?@G+,=]7QBS#&/$PJ2]U2YO=2N^K]V]UI'W5RZ/MXU^P5^Q9X"_8
M!_9@T#]F7X=^(=0U:UT<S3W>K:EM66]NII#)-+L7B-2QPJ G:H +,<L?6!X@
MT-=7_P"$>;6;,7YC\P6)N5\XI_>V9W;??&*NG..*^&[_ /X)K_'N[_X*(K^T
MTGQ,LQX:7Q7'KGVHW<OV[RE</]@\L*!L('DYW;?*/()^0_.8&AALRJUIXS$*
MFU%R3:OS2[=-_P#AD>_GV99IDE'"PRW!/$*52,))24?9P?VW=.Z7R7=H^N/B
MO\=?A%\#;"QU/XN_$#3?#\&I7?V:QDU";:)I,9('!P .2Q^5>,D9KJT=74.I
MR",@CO7GOQ]_9<^"/[3UEI>G_&GP6NK1Z-=-/IS"ZEA:)F #KNC925;:N5)P
M=J^E>@011P0K!#$J(B[555P !T %<-3ZG]6I^S<O::\U[<N_N\O7:][]=CUL
M/+-O[0KJNH>PM#V;BY<[=GS\Z:Y5K;EY6]+W'T445S'HA102 ,FO$?BI_P %
M)?V"_@?X^U#X6?%W]K+P3X=\1:2Z+J6C:IK217%LSQK(H=3R,HZL/9A6E.C6
MK2M3BV_)7_(SJ5:=&-YR2]78=^UY_P $[/V.OVY_#XT7]I/X)Z7K5S'M^QZ]
M;J;74[7&<".[A*RA.>8RQ0\94X%?FW^T7_P:3^ =5U675_V5?VI=0T6W9"8]
M$\<:6MZH?':ZM_**IGC!A=@/XF/7]<OAA\4OAU\:? >F_%#X3>--/\1>'=7B
M:73-9TFY$UO<JKE&*..#AE93Z%2.U;V!Z5Z&%S;,\O\ <I5&K='JON>QPXK*
M\MS#WJM-._5:/[T?S/\ QP_X-O?^"I'PAO9%\/?"[1/'EC&,KJ'@SQ%$X;V\
MFZ\B;=ZX0C/0FODGXA?!K]IG]E#QI#!\3?AKXT^'NO6K>9:R:IIEUIMPOH\3
ML$)'HRD@]C7]BV/:LGQMX"\#?$KP[<>$/B+X+TG7])O(REUI>M:;%=6\RGJK
MQRJRL/8BO>P_&6*CI7IJ2\KI_JOR/ Q'!V$EK0J.+\]5^C_,_G$_8._X.*OV
MXOV4-3TWPK\8_$LWQ5\#P2[;O3?$TY?5(83WM[\YDW XPLWFKM&T!,AE_H+_
M &4_VI_@[^V7\#-#_:!^!?B/^T=!UJ$E?,79-:3+Q+;3)_!+&WRL.1W!*D$_
MA7_P<3_\$H/@U^PWX@\+_M#?LV:=_8OA/QIJ$VGZEX5#,T.F7Z1^:KV[,Q81
M2IYG[L\1M%\IVN%3U+_@TA^.6NV_Q1^*W[-ES>32:9>:#;>);*%I#Y<$\,Z6
MLS = TBW$&3W$(ZX&.C.,#E^895_:.$CRM:M6M?6SNMKKNM_/0PR?&YAE^:?
MV=BI<R>SO>VEU9]FNG3RU/5O^#N#XG7VB_LY_";X0VX(A\1>,+[4[AU/7[#;
M)&J_0F^S]4%?.?\ P:>?!KP[XQ_;#\>?&+6]*ANKCP7X*2'2))H]WV6XO9PA
MF0_POY,,T>?[LKCO7NG_  =X^!M3U#X6_!'XE0VK-9Z3K^MZ;<3X.U)+N"TE
M13]192'_ (":\M_X-&O&EC8?M!_&#X>27"K<:IX-T_48H^[1VMVT;'\#>)_W
MU6F']W@R3AOK?_P.S_ SQ'O<914]M+?^ 77XG[N 8HHSGI17P)]X%?/O_!5/
MX!Z!^TI_P3S^+7PNUVT>:1O!=YJ6DF+[Z7]E&;NU(]O.A0-CJK,.]?05>1_M
MZ_%+0_@Q^Q/\5_BAKVI0VT&D?#_5I(WG;"R3M:R)!$,]6DE:.-1W9P.]=&$E
M4CBJ;AOS*WK?0Y\5&G+"S4]K._I;4_E=_8:_Y/5^#W_94O#_ /Z<H*_K^K^0
M#]AG_D]7X/?]E2\/_P#IR@K^O^OKN-?X]'T?YH^1X+_W>MZK\F?B#_P=XY_X
M3GX'X_Z!.N_^C;.G_P#!HI\*] U'Q9\:OC5?6^[4],L-'T739,C]W#</=3W
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MX+?MB7W_  4<U634-)UBUU>;7IH=6\1)#HMCJ$I8O>8=05.^0N%:38KD84
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M\:S^'9^C_P M_D>7G&7_ -IX&5%?%NO5?Y[?,_*/_@V)_P""G?A#PUX?N/\
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M37PCT3XW_!+Q?:ZYX<UZT6XL;ZV;I_>C=>L<B-E71L,K @C(KM!7\CO[%_\
MP48_:X_8#\3R:_\ LV?%2XTVSNI=^J>';U!<Z9?M@#=+;O\ +OPH'F+MD &
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MOP?_ .RI>'__ $Y05_7]4\:_QZ/H_P T'!?^[UO5?DS\0?\ @[Q_Y'GX'?\
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M9?\ (LA_C7Y2/W#_ .""7_*(_P"#/_8)U'_TZWE?7U?(/_!!(_\ &H_X,_\
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M)?CK_P %#/%VC?LC_M;_  FN)/%WB:[U*Z\*:[X@EM;[1[J>5IKBV58X9$N
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M#QIK?G79L-0/GRS6V]FS+%&(XLQY)1;UL=4 ]J_94_;L_80_X+;?!;QEK/\
MP40_99\-V_B3X,Z'-KU]-:23L'T@(6FGM9499XP'3:]N7926B8%B<+\^?LZ?
M\',/PW_9M\1:?\(/A%^P+X=\'_!JUU0JEAH&IO\ VM#;O)\]VQ8>7/<;/F*L
M?F("F7&&K[B*QTLN6#H8>U6DXMOW;)K6Z=]7);KS=SXF4L#','C*^(O2K*22
M]Z[3T::MHD]GY(SO^">O_!$S3?@=_P %$_"]A^UQ^UM\*UNO!/B*#4K#PAX8
M\22W-]JVH6\@EMH6\V"-(5,BQNT;'S74; @W;E_1+_@N?\#OVC/C;\ O#*_
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M[3_97_8:_90_8I\,-X5_9F^"FC^&(YEQ>7UO&9KV\Y!_?74I::49&0K.57L
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MT_6M/N)KO4;57VK+-,LR>6[*-P5% 3?@[\9KZ*_X*2_L+_#7_@M3^R[\+_\
M@I5\-_C)X>^&.K-X-BMKY_B!>_9]-:T\^5C;2W/2%X;I[A5?:5D$G.WBO#?!
M'_!#C]@;_@I5\;_$'Q>_8!_X*"67_"!?VPEUKW@__A$Y_P"U-$69F9HHQ<-
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M8ZIGTK^VS^WE\*/^"9OPV\(^$H?A_?:_>7=E]B\.Z':WBVZ):VB1QEI)BK;
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M XQAACYE7(S\@?$'Q1X?\$_\%O%\8>*]5AL=,TNRDNM0O+AL)#"GA^5F<^P
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MTEO*[[]?C\1P/E.;87%XNMFDI4<7)2IM?#%J3:WDU)13<;6C9*VG2#_@@?\
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M-Q=0<[%-=%_P4C^!RZG^P%JWP^^&?A]OL_A&SL;C3=.A9F,5G9E5906)+;(
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MPLXGG<>ZQ*Y_"OU%\*^._!GC@WZ^#_%-AJG]EWS66H_8+I91;W"@%HGVDX8
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# /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>smti-20240910.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaaGubP9z5Z82ekhvWB/bVma/ykk3It7DSXGwrTmcekB -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:SMTI="http://sanaramedtech.com/20240910" elementFormDefault="qualified" targetNamespace="http://sanaramedtech.com/20240910">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://sanaramedtech.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="smti-20240910_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="smti-20240910_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>smti-20240910_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>smti-20240910_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://sanaramedtech.com/role/Cover" xlink:href="smti-20240910.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://sanaramedtech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139837568941264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Sep. 10, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 10,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39678<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SANARA
MEDTECH INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000714256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">59-2219994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1200
    Summit Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 414<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Fort
    Worth<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">76102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(817)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">529-2300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.001 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SMTI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MW&,EC'%BM/XU@LD/['X 4$L#!!0    ( *6 *UFJQ"(6,P$  "("   /
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M              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%
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M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( *6 *UDD'INBK0   /@!   :
M          "  <@1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( *6 *UEED'F2&0$  ,\#   3              "  :T2  !;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /<3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sanaramedtech.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>smti-20240910.xsd</File>
    <File>smti-20240910_lab.xml</File>
    <File>smti-20240910_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "SMTI",
   "nsuri": "http://sanaramedtech.com/20240910",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "smti-20240910.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "smti-20240910_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "smti-20240910_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://sanaramedtech.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-10",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-10",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://sanaramedtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001493152-24-035783-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-24-035783-xbrl.zip
M4$L#!!0    ( *6 *UF$VE.WCQ8  &-W   *    97@Y.2TQ+FAT;>T]:W/;
M.)+?5:7_@//-3B55E&QGULG%]KA.EIW$NWZ=I4PFGZX@$A(1DP0'("5K?_UU
M-P!2HI1,O)=DHAFE*HDE$D"CT>\'?/QF>'5YTFX=OSGOG<'_#/\<#R^&E^<G
MQ[OV?WBZZQX?G]Z<O6>#X?O+\Y]WQBHK#MG^7EZPH4R%8==BQNY4RK/ ?A&P
M@=!RO ,#8>CM8\<=L93KB<P.&;ZZMW-R_.KF>K@X2V?,4YG,#W]O'GK7R'\)
MN^S.R8_9R.1'Q[LX(>SSM@%A(1Z*#D_D!-;6<A(7=HH_&.CCTY/SAUB.9-%N
MO7S9W3_>/3WYZ!:^ WA_!\E_.(1';,3#^XE6919U0I4H?<AFL2P$+'%Q]9H-
M[OH_[XB'ER\[^_^[M[??_9!/=ECO<OCSSHY?/19('8?LX$7WQ0'..)-1$</T
M+YYU#^C,-G'WC^".#Z4IY'C^'?#'IT[S]&3 ,ZYYNW4EHJ$(8W:1A5W&LPA^
M&)>#N2E$RMZH))+9!%:@I[TL@[E"P<X?PJ0T<BK8VPSFB]B@X 5 =B9-H>6H
M+*3*6&^BA4A%5@ )%'% <U_)3&E9S&&^J3 %/959T&[U8Y&J*U46<2Y%* )V
M>=G_OKGYT]CU!//E=W#$UE#;M]K6JYN[8;OU#OY] _/\RG;9ZT2-!$QN9E(+
M^#P0.5#.2&BVOQ^P9WO/_LYV+3(LP;$%>D/T=-DI-T!!,F.OE"[8._@'B&4H
M'CC"N#*FRY[\F$2_E<K-%_RHZ5.[5<2"N4=]E>8\F_MG_NN9:'ZC2NV_4=I_
M61KWW5/VY+HW..O]SR$;7 TOG@(-LU1$,N0)'$(89X">R9R%=C7 9%C"5MHM
M('Z9YEI-@7=8F,B,1@!QPYMP%,@(6D1EB(]CP9,B#CD@3SSD(HMD46IX"?"!
M&S(E'#V,#E@8:P43L1F>#,UA[F5& X$^[D5A@@;[ ELM(:Q^XO<7T!HJ%YHC
MRP*0IAP9&4FNYTR-'?I_U ;?-NR#DL"O4V!: )'E7!<9G/-'Y07"8P4&X*10
M$9_3<N)!A%9"P H\@\_KA4FT*$SX&F&2>F$BEX0)6R=+*B0T'GI,=/\\;/IU
MC(P_;C]W*FNWKN6#RH(F0?;/;P)FD%RBP'/OC08R3LM0&5E(X"/@-Q:)D4PD
MO$<,J9#)I&52'M)W,2P++&F0)(M8E0;HBSZH++1,GL-@(##3;@%1ESQ)YMTF
MH;&8 ]6*J4B HX!%*]9/YFP*B(L03@9R 5C?TC%[==9C!_M[3^Z?PLL"MH;:
MM8AYP4+@C)%&V+1(I "P%./CL0AI#@=,M]T: D?U4L I#KARPJEGC HE\30!
MI0&ZK  PI#$EC$<V[-\. 1618$\$38L,^(\2WD&9_127&PG&\QP6C^"T-,M5
M 9-(F%X+F8Y*;2Q#CN;M5A[/C805,RO=<CX7VM H7 JDHN-UA8<3\BER+6!*
MPF[Q)4"5GBMX5?-\CA@"D8$B!H0@G-8'$"&T%4)9B$AWKW89;M]A%$X&B=.P
MF4@2^VZ#7"J!"8(%SF(R#Y#&0*_ UTD9 ;DBM E E:%*@I-/^$1D+ >=)O'Q
M6*N4#<MQ85!636&/N!$Z+Q+^#$E5\\BA/A(ZA9^ #+OL'4RLU#UN=\9UA/@E
M#8'RTIX'[HLM2B8Q.7((6T".PQH,7R%-!D0L] 2$]*3=6D*3DW)_'IGP9Y-Q
M8%H-@?D-)T)OMVZ MJ92S/YT!N3'[>)A[_3R'"3ZY>5M[^SLXOKUSSM[._1Y
M<-OK^\\./N]4[NW][?&.5J=0^2'BP7T<J:)0Z2$Y!\.[QV,7SJI L>M1"M-C
M@.=X>/;XN=S&]KK/#F2&SO+P[.2+3/3E8AC_^?+YBY<U[_V[ 'Y5(MPY:>AF
M%\?[S#]JYA09K%2.@2G)).=+JAH4A)?%*/]!QYDE00T2FHQ\0=(=- QHD.RQ
M@)"9#Q8%F;EHCC2,FVR=\ ?U!B@J5*$>P%]85 2LT(*3H6RZ2P>X.[S#?Y %
MOXR0L?]V@?:^^DFOUP5;<;(5)U\0S,'%XQCW3>W6#WVD0.("Y(N.=^]W.1M<
ML'?DS/?A-7KRM YN7"R-JQSV1XH/=K"W>[#7<-Q'HI@),&M=<*41-("C!O-Y
M))RO[GQSRV252Z[T(P7JN.DL54;YO2RJ:,=2 & KH;82:BNAOIJ$6A0O+$_0
M=2^4I50;3R3!4'&\E0<^>%'$8-]/XL78'\8G<GC^(,'V$,G\<=#\%.SM[6'0
M(Q2:8; "?&L+S.I2E>@0#P =&3P\0>==\/2;"8VM?-C*A[^.?"";("]U&',C
M/%_6XH!T. 7'FB%1\(PX&\L'"GRBLP1"Y7%PY'P.4V@U!X,*?*",92":-/A$
M62E60HR+0(')(Y)$@/,&/A-\F0-5SKML*R"V F(K(-8)"%<0\!CFM)DW8.X?
M#ABLFF#4VP;TGW>?_PWC**#'8YFSG"(6F'/)FC)BJ[*W'+GER*^CLF,^!95;
M:6ZF<F)"BEB*AUQB6!,^_X-G):;\?[(E&R\I.^7'@$Y]'!AONX,N&Y5&9L*8
M-:Y_X/)M:+ES )+>7ZNM,?=)25. Y]%@.#M@&T;8RIRMS/FJ5@#5/6@^R]@/
M^P?=VA) =5^@7ZY3EBCN$OC]N]>X^E1B_9,-B&*D@>35&,.A14RI#5_3\\B0
MIZ'").L,@)1#N+ZR"/B#&/^[![L)\']T.NR5%$ETR&[Y1!S!P-]*S(G!@"-V
M0ZK)'.(" T%Y\"/V"T]*?,PZ'5>*?WQV\8N'KB&'GE/R6>E(Z.J[TX2']VP?
M]FM4(B.45(^1EVXVJ@3)#4#B?ZKKFBM1NKSW6B"N$7/+J$_$F$94PF#QH8V%
M+2VW<])9Q*7'XA$;SG, H*?Y2(9'[)JGPF+Z6B'^]A<'[?I1^*2SRAC'NX#G
M-2@?:<'O.R,!1CY,GM,Q+FJ'Y[3YV^43(H*KR?AV>?9%J!!:>]:;0.";RI>G
M)U@DUVY=^43R!I:9;':5-4&_D7!;RJE+$$).E0\YE]FX3%B*5CXKDQ#\?E]=
MATE0CE72J<JH6#H!<>@+@)?*$Z@RVI?/==F%RPJ"?T"5RC@/_LT8F :49HC:
MK8.]/<H=_)A%W,1';!\_T3=5:<0L5M83:I1/^$I.6I?2G7Y:5U+-<.>8!!58
M&_K#<YC4V39=ULC0MELCK-.<4A$AS%V7>8)98V(U8SBQQO))6+ZPM2&D\2A@
M4A7S514:/@L2N%IRX??#?@.@73U((L<44D4_"I888UXVA".3&95Y5G,AHFUN
MQ:.:*CH=@E8K6:5-"654G(B^X"B1)F:F *^M+DX?EY1/U@+.7NG05S**\1@.
M.)RW6S8B*_6J+[8IY+ZA(OX.^(YKX(XSF2@M5; N?;:N>GIM30 C2J0F#:P[
M+;6O_:?0GL2RW@A)2[F*Y4)-!-(9O0H,/Y(9M0 @N]AFAL66 UP+A8, "L(.
M!*#:;%+$F(YD$? 4V$\4$-!2%!BD<.0E55EQ&;U;4_,[K'$@9K2\6'<85&T$
M0;MEA=.HE$E$09#&OEPAA&6LTD*CK$\Q0MX;"^T)?NG</EK]N+; %WAD?86O
M(SG"#F$5%ULLP?9%X4OEZH[)*\EG2@\G96>6Y=^&E@5O+%.>\:D$-GBOS+T"
M3_A?*YTJ%6?>:F&P7-#FX(%/FVSZSFK"/!'4/%4X_69$8AL$&LH)O6(D[XH1
MVJVE[AK?RK.V#&>9G8#\UV;B@:$E^A,1I>&1%@W IH#Q%PK5M1H+8XCMP7(H
MM::N!%!9P&5(I-CHLUA#X,H"*$"X7!O@F#,,8<=8RV^3@'G![ZL\8)/?@IJ/
M.#)!W,E K2-\N2VZ7E2)=J<S52;P'#ES)HUP[&1Y"9=8ZBNQ;11FM4S3\QDC
M F \BI9/DBHWX8#)".&%[61S75*(<X?/YIEBU(6S1&'["ARFLBU;"2^S,"9A
MX64C26UJ]/('87*.^+"2MP0JBM;U2X!L^IS\#0A*2XU@>(PMU1+R8,6Y/2:[
M%^$:VN#,C$%;T8+JC^L10A0\E\]KDW B8BOHOBW8MS*\G\'?=JO/<V"/A-TZ
MO4KA/C ZA)YBAY19+C($UIA*H\B2:%JDE+4 75[4;1);:_(38'^J#>.;='KT
M1G!XWZZQ^_M$PC<.4/RQ^VT>=;N%L7UJP 3C?6HU>BQ H_HF:M= X1NH;<#>
M-E":AE\  )C*#9BO"OQ*VZ$6;YC!KDWR<1UVLZ5FSA'96<K:1V#K&')=:K,'
MM1BF+$#5Z@!@()WNK;> K9I^&).8Q2)CD>233!FO@M^H:'(OL\JRNIRG>0SG
M$BS96(U QEB"_1##:EWVAF1DY??;H+IO< 0/#CM0P#[(R:%)8?0$K2?73BU3
MC'?0%KG,NNR]**S4I2A/Q#+\#T AW$CTP\JDH(G@]0+^HGF [U,8*' 5I#!.
M%:SJ,DVP8UXESLP!=T:+I;Y0ZY>A31)+*BN%)35\8^M*1J(HT+/,;8CH\>>*
M:P/T8-K8E/(J! %M%TVH*5BP8-6@I4P:I^X7==MA!KS#A8Y^UT(Z1I^Q&=QR
MQO720D4,GN4$CPO-X.I2 'Q/2W./<S@:)/-XV:RDS2_ND&QG#O"A:3C"$G]K
MMA'.;>S&MO)&(N21NXG@H[VG'W5-:7H#<D>B(^Z<%!>D0O-V"M_Q"586H.L.
M^$.VL+[^XF28\=?N$6SF%<"5*FKZ!1!3%R#,UFN0P+D^#.P%65"6<29&\"-5
M',YFLRZA/JV+C$"2?!M[X1O(X+^>:JGMB34W@OQU<+"Q^8Y/;&OM/41D-/S^
M52N,FNPK^=BT&$B4HK_@! HYTPL>-.@6'UOW5S6 T%NYID5\R4M:G,IR^ZAN
M;JG[+(PMD:[,H'KR-9,N63U8 ST"2VCY+@:[,_J(RED9\LA@2?O ^/0!Z@H@
M '+4[24)H&GQ,A>\\2*R 4_C8 AM&B9R-QS8LYE*3<5;J##!++ "W%"A!VQJ
M*CD@/Q%TJ#(3W>;E#-56[+XDH$:BVE))Y/#<;EWCY4#U=1>D:M <:D#E4<8*
MNN\"3A',&5V?@),A[G.CS\6P/A:B85#I[M?CP=O;$]*&Q[OX(QNXJ=NM'AHS
ME"OJNWLB H;7(UV\>L^&=Z]71@XM+'<6EM>:CZWB]&->7=Z\P]3[RL#S!Z#A
M$& J$Z[9%0<X']!UQFLNX&S(O :\C%4B%5VSX;$RDD3HX2*5A-:PP>NY^L.+
MU^?7M-SPRJWU"W(O6@D7&:6G@#-.52;<J@'K75[>]-\/5X!LMV[!A6<]O_0O
MDH^2QMA3"5N]6MG>J53<KG0%1TW#_(CA^:\]#^+BD%Z:257 QJY$.@+^%JR7
MP$X1I8&EUM.+WN#MW>M59%80^H-D Y78(*@+DE7$8\F#LI \LC?&V/N2 --@
MWRV%V(A?:DJU!(EQS8KQ#Q&F?]X,5B$" RB5H58CC.L/@+.)+%QG*%@Y&?!0
M\'FC[:#7(JG1\.@E+[1&GP QXE&SRJLR%R ]@-L2HY#AT?8W=7H"C=F&X/7Y
M4.#;B&["L3++>2 N&:QRI.0RP[:N$-VW6 %?60X%:A[+)/5B4(N. $D&[B2)
M>CN%E7<*CA#,Q$S #F$> ,6R7B1&6D;VTAIZ$^^)(8U22"0[O/N*+H9I".DJ
ML0N69NQB5IP"O]3E'VG<'YJ@%5HH0 QH"45>V)M>1*U@:J%L/6 4\_9FJU@"
M%*D0%$[V65ZKAB; _!3BU>*W$OP5V\/O)1EZ:.BF<+KDQPAQCS-@:+A#Q7?N
MOAO":97@ L%.'B>O[JY92*>A)^YU8ZT1"PHXS]#_ M.>)S:7O6EQN+_2O3*?
M7X+W;%MM]R6K[9YMJ^VV3/MEF':#=U*Y[1^])/+/Y<QNLH^^<U(?4KO5N/KW
MR?7[P7GE>1VRB^M7;Y\&UD\'&Y5Z>3)?T6/=9>]%D@/H+KM#2W;,PSII#L3A
MR]KH=8I.EIK< .?_MUMH\E@3:>$^)FW-PL6U_!I@&"%\M?.Y\#!B+C3/BIGJ
MY&!5H8W*4A6)Q)I]%$QGU1/8XJV%L-T:N F#QMU]"0?7.47KS7AO@M(09.6!
MJ.[$8#\M1A%F5,R(0UVUG@U5^+"]S*8J08N3JB7%PZ=08J^(LG#9#3APF8<6
M'D_LM'9"+2ET,F8WKAX@@"'@ UR!,3FIS6/K#@Q=M-;W<_E%C,![--LMCZ>
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MY@S^<%_7R3T=W"N'3]*^2^P@?[<A;W?)#23!PN JL5^._OUHI7LOF&[6[,&
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ME^U5A[5JRS[ZJ#B2[=C&&/_N>P.S\O]02P,$%     @ I8 K63L];,HH P
M\@L  !$   !S;71I+3(P,C0P.3$P+GAS9+56VW+:,!!][TS_0?6[+0S-!0+)
M-,DDPPRTF9#;]*4C[ 4TV)(KR4#Z]95\XV)P@;9^DE?GG-W5[LIN7RW" ,U
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MB!R?%L'\'1SK]H@N*#O?U@)MG*KIY6]02P,$%     @ I8 K6=A]B'3^"@
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M     &5X.3DM,2YH=&U02P$"% ,4    " "E@"M9BD@L0X 8   )JP  "P
M            @ &W%@  9F]R;3@M:RYH=&U02P$"% ,4    " "E@"M9.SUL
MRB@#  #R"P  $0              @ %@+P  <VUT:2TR,#(T,#DQ,"YX<V10
M2P$"% ,4    " "E@"M9V'V(=/X*  " A@  %0              @ &W,@
M<VUT:2TR,#(T,#DQ,%]L86(N>&UL4$L! A0#%     @ I8 K63Z0HJC>!P
M^EX  !4              ( !Z#T  '-M=&DM,C R-# Y,3!?<')E+GAM;%!+
4!08     !0 % #8!  #Y10     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="smti-20240910.xsd" xlink:type="simple"/>
    <context id="AsOf2024-09-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000714256</identifier>
        </entity>
        <period>
            <startDate>2024-09-10</startDate>
            <endDate>2024-09-10</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-09-10" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-09-10" id="Fact000004">0000714256</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-09-10" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-09-10" id="Fact000010">2024-09-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-09-10" id="Fact000011">SANARA MEDTECH INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-09-10" id="Fact000012">TX</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-09-10" id="Fact000013">001-39678</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-09-10" id="Fact000014">59-2219994</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-09-10" id="Fact000015">1200     Summit Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2024-09-10" id="Fact000016">Suite 414</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-09-10" id="Fact000017">Fort     Worth</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-09-10" id="Fact000018">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-09-10" id="Fact000019">76102</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-09-10" id="Fact000020">(817)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-09-10" id="Fact000021">529-2300</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-09-10" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-09-10" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-09-10" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-09-10" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2024-09-10" id="Fact000026">Common     Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-09-10" id="Fact000027">SMTI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-09-10" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-09-10" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
